ZA728821B - 8,12-diisoprostanoic acid derivatives and process for their preparation - Google Patents

8,12-diisoprostanoic acid derivatives and process for their preparation

Info

Publication number
ZA728821B
ZA728821B ZA728821A ZA728821A ZA728821B ZA 728821 B ZA728821 B ZA 728821B ZA 728821 A ZA728821 A ZA 728821A ZA 728821 A ZA728821 A ZA 728821A ZA 728821 B ZA728821 B ZA 728821B
Authority
ZA
South Africa
Prior art keywords
diisoprostanoic
preparation
acid derivatives
derivatives
acid
Prior art date
Application number
ZA728821A
Other languages
English (en)
Inventor
C Gandolfi
G Doria
P Gaio
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of ZA728821B publication Critical patent/ZA728821B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0016—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0033—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing sulfur
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/12—1,4-Dioxanes; Hydrogenated 1,4-dioxanes not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
ZA728821A 1971-12-17 1972-12-12 8,12-diisoprostanoic acid derivatives and process for their preparation ZA728821B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT3252071 1971-12-17

Publications (1)

Publication Number Publication Date
ZA728821B true ZA728821B (en) 1973-09-26

Family

ID=11235473

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA728821A ZA728821B (en) 1971-12-17 1972-12-12 8,12-diisoprostanoic acid derivatives and process for their preparation

Country Status (17)

Country Link
US (1) US4089896A (xx)
JP (1) JPS5747188B2 (xx)
AT (1) AT340607B (xx)
BE (1) BE792803A (xx)
CA (1) CA999857A (xx)
CH (1) CH585197A5 (xx)
CS (1) CS174189B2 (xx)
DE (1) DE2261496A1 (xx)
FR (1) FR2163697B1 (xx)
GB (1) GB1420338A (xx)
HU (1) HU168381B (xx)
IL (1) IL41033A (xx)
NL (1) NL7217104A (xx)
NO (1) NO144488C (xx)
SE (1) SE415095B (xx)
SU (2) SU694069A3 (xx)
ZA (1) ZA728821B (xx)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4096342A (en) * 1972-09-15 1978-06-20 The Upjohn Company 8β,12α,15β-PGE2 compounds

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3969396A (en) * 1972-09-15 1976-07-13 The Upjohn Company 8β, 11β, 12α-PGE2 compounds
US3975426A (en) * 1972-09-15 1976-08-17 The Upjohn Company 8β, 11β, 12α-PGF2.sub.β -compounds
DE2460285A1 (de) * 1973-12-25 1975-07-03 Ono Pharmaceutical Co Trans-delta hoch 2-prostaglandinverbindungen, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE4024345A1 (de) * 1990-07-27 1992-01-30 Schering Ag Cyclopentenderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4100355A (en) * 1972-09-15 1978-07-11 The Upjohn Company 8β,12α-PGE2 -type compounds

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4096342A (en) * 1972-09-15 1978-06-20 The Upjohn Company 8β,12α,15β-PGE2 compounds

Also Published As

Publication number Publication date
SU694069A3 (ru) 1979-10-25
AT340607B (de) 1977-12-27
IL41033A (en) 1977-10-31
DE2261496A1 (de) 1973-06-20
ATA1070872A (de) 1977-04-15
FR2163697A1 (xx) 1973-07-27
CA999857A (en) 1976-11-16
BE792803A (fr) 1973-03-30
US4089896A (en) 1978-05-16
NO144488B (no) 1981-06-01
JPS5747188B2 (xx) 1982-10-07
JPS4867257A (xx) 1973-09-13
HU168381B (en) 1976-04-28
NO144488C (no) 1981-09-09
SE415095B (sv) 1980-09-08
CS174189B2 (xx) 1977-03-31
SU626692A3 (ru) 1978-09-30
IL41033A0 (en) 1973-02-28
FR2163697B1 (xx) 1978-02-10
GB1420338A (en) 1976-01-07
NL7217104A (xx) 1973-06-19
CH585197A5 (xx) 1977-02-28

Similar Documents

Publication Publication Date Title
CA1010892A (en) Phenoxy-alkyl-carboxylic acid derivatives and process for their preparation
IL45299A (en) 16-phenoxy-11a,15a-dihydroxy-17,18,19,20-tetranor-5-cis-13-transprostadienoic acid and prostadienol derivatives and prostadienol derivatives and processes for their preparation
ZA725057B (en) 4-phenoxy-phenoxy-alkane-carboxylic acid derivatives and process for their manufacture
CA979437A (en) 15-oxoprostanoic acid derivatives and process for the preparation thereof
ZA725520B (en) Aminobenzimidazolcarboxylic acid derivatives,process for their preparation,and their systemic-fungicidal and bactericidal use
IL39735A0 (en) 3,20-dioxo-pregn-4-ene 21-carboxylic acid derivatives
ZA728821B (en) 8,12-diisoprostanoic acid derivatives and process for their preparation
GB1407478A (en) 11beta-alkoxy-estra-1,3,5-10-trienes and processes for their preparation
IL37854A0 (en) Substituted 2,2'-biimidazoles and process for their preparation
AU458645B2 (en) Thiohydroximic acid derivatives and process for preparing them
GB1400603A (en) 5-nitrothiazole-2-carboxylic acid and derivatives thereof and process for their manufacture
IL39058A (en) N-picolylalkanoyl-piperazine derivatives,their salts and process for the preparation thereof
IL40133A (en) Thiazolino-pyrimidin-5-one derivatives,process for their preparation and applications thereof
KE2693A (en) 1,4-methano-and ethano-tetrahydronaphtyl-oxypropanols and process for their preparation
IL39945A0 (en) 14,15beta-epoxycardenolide-and 14,15beta-epoxybufadienolideglycosides and process for their preparation
ZA733967B (en) 9-desoxy-prosta-5,9(10),13-trienoic acid derivatives and process for their preparation
AU467163B2 (en) 8. 12-diisoprostanoic acid derivatives and process for their preparation
MY7700076A (en) Prostatrienoic acid derivatives and process
AU4977972A (en) 8. 12-diisoprostanoic acid derivatives and process for their preparation
PH10379A (en) Thioallophanimidate derivatives and process for the preparation thereof
YU36734B (en) Process for preparing 7-amino-3-zs-(1,2,3-triazole-5-yl)-thiomethylc-3-cephem-4-carboxylic acid
CA862764A (en) 3-cycloamino-1,2,8,9-tetraazaphenalenes and process for their preparation
EG10547A (en) Process for preparation of 1,5 benzodiazines
KR780000086B1 (en) 1.2-dipheny-ethane derivatives and process for the preparation
ZA728473B (en) Prostatrienoic acid derivatives and process